99 filings
Page 3 of 5
EFFECT
895erjga
19 Nov 21
Notice of effectiveness
12:15am
8-K/A
dpjd9v
18 Nov 21
Departure of Directors or Certain Officers
5:03pm
CORRESP
qs6pdtq1bal6j5z 46z
16 Nov 21
Correspondence with SEC
12:00am
UPLOAD
whts l9ap
15 Nov 21
Letter from SEC
12:00am
S-3
8g6c6or
12 Nov 21
Shelf registration
12:00am
8-K
dvj crfb31u7718
4 Nov 21
Departure of Directors or Certain Officers
4:58pm
8-K
eqd5vapwphf4b4wav0p
26 Oct 21
SQZ Biotechnologies Announces Independent DSMB Recommendation to Advance Lead Cell Therapy Candidate into Combination
6:54am
8-K
yay37d8438q5h5larr
13 Sep 21
SQZ Biotechnologies Announces First Autoimmune Disease Indication
6:53am
8-K
2iey19y
2 Sep 21
Departure of Directors or Certain Officers
5:00pm
8-K/A
enrg4
29 Jul 21
Departure of Directors or Certain Officers
5:00pm
8-K
lsa5adtrbsyxwq49j6o
1 Jul 21
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
5:07pm
8-K
5l89bc5pw6e87gtvux7d
17 Jun 21
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
ratv 431ks8
4 Jun 21
Regulation FD Disclosure
8:09am
DEFA14A
gkgxjs3r ixhi19
26 Apr 21
Additional proxy soliciting materials
5:10pm
DEF 14A
wqkllj6 19
26 Apr 21
Definitive proxy
5:00pm
10-K
awa7n
18 Mar 21
Annual report
6:31am
8-K
z6ke0x4wn
25 Feb 21
Departure of Directors or Certain Officers
5:00pm